Ballentine Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,675
Closed -$229K 976
2024
Q4
$229K Buy
+1,675
New +$229K ﹤0.01% 727